# HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy

> **NCT04768517** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Hepatitis C Virus Infection
- Hepatitis C Virus Infection, Response to Therapy of
- Human Immunodeficiency Virus (HIV) Coinfection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04768517
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-09
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2021-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04768517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04768517, "HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04768517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*